B precursor type acute leukaemia and Transaminases increased

Summary:

Transaminases increased is found among people with B precursor type acute leukaemia, especially for people who are male, 20-29 old.

The study analyzes which people have Transaminases increased with B precursor type acute leukaemia. It is created by eHealthMe based on reports of 24 people who have B precursor type acute leukaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is B precursor type acute leukaemia?

B precursor type acute leukaemia (lymphoid cancer) is found to be associated with 30 drugs and 106 conditions by eHealthMe. Check the latest studies of B precursor type acute leukaemia.

What is Transaminases increased?

Transaminases increased is found to be associated with 1,155 drugs and 1,514 conditions by eHealthMe. Check the latest studies of Transaminases increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

24 people who have B Precursor Type Acute Leukaemia and Transaminases Increased are studied.

Would you have Transaminases increased when you have B precursor type acute leukaemia?

Gender of people who have B Precursor Type Acute Leukaemia and experienced Transaminases Increased *:

female: 16.67 %
male: 83.33 %

Age of people who have B Precursor Type Acute Leukaemia and experienced Transaminases Increased *:

Common co-existing conditions for these people *:

Rashes (redness): 1 person, 4.17%
Pituitary Tumor: 1 person, 4.17%
Infection: 1 person, 4.17%
Hypotension (abnormally low blood pressure): 1 person, 4.17%
Hypertriglyceridaemia (excess of triglycerides in the blood): 1 person, 4.17%
High Blood Cholesterol: 1 person, 4.17%
Blood Bilirubin Increased: 1 person, 4.17%
Bacteraemia (presence of bacteria in the blood): 1 person, 4.17%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 1 person, 4.17%

Common drugs taken by these people *:

Common symptoms for these people *:

Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 5 people, 20.83%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 5 people, 20.83%
Febrile Neutropenia (fever with reduced white blood cells): 4 people, 16.67%
Thrombocytopenia (decrease of platelets in blood): 4 people, 16.67%
Hepatotoxicity (chemical-driven liver damage): 3 people, 12.50%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 3 people, 12.50%
Nausea (feeling of having an urge to vomit): 3 people, 12.50%
Nausea And Vomiting: 3 people, 12.50%
Pleural Effusion (water on the lungs): 3 people, 12.50%
Pneumonia: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Transaminases increased?

- Check whether Transaminases increased is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Transaminases increased and B precursor type acute leukaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.